Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Skinner

Showing results (531-540 of 554) with videos related to

Pageof 56
Sort By:
JAMA Network Open|January 4, 2022
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic WorkflowDavid E Godler, Ling Ling, Dinusha Gamage, et al.
Oncology|April 30, 2018
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large CohortElena Elimova, Xuemei Wang, Wei Qiao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2022
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltrationDavid C Wilde, Patricia D Castro, Kaustav Bera, et al.
Oncology|July 7, 2017
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative TherapyDilsa Mizrak Kaya, Xuemei Wang, Kazuto Harada, et al.
British Journal of Cancer|July 21, 2017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patientsRoopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, et al.
Targeted Oncology|December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialKazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
Oral Oncology|October 26, 2019
Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based MeetingV C Sandulache, Y L Lei, L E Heasley, et al.
Nature Cell Biology|January 22, 2019
An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapyPeter H Liu, Richa B Shah, Yuanyuan Li, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Cancer Research|February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsAbdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.
Pageof 56

Showing results (531-540 of 554) with videos related to

Sort By:
Pageof 56
JAMA Network Open|January 4, 2022
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic WorkflowDavid E Godler, Ling Ling, Dinusha Gamage, et al.
Oncology|April 30, 2018
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large CohortElena Elimova, Xuemei Wang, Wei Qiao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2022
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltrationDavid C Wilde, Patricia D Castro, Kaustav Bera, et al.
Oncology|July 7, 2017
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative TherapyDilsa Mizrak Kaya, Xuemei Wang, Kazuto Harada, et al.
British Journal of Cancer|July 21, 2017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patientsRoopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, et al.
Targeted Oncology|December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialKazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
Oral Oncology|October 26, 2019
Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based MeetingV C Sandulache, Y L Lei, L E Heasley, et al.
Nature Cell Biology|January 22, 2019
An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapyPeter H Liu, Richa B Shah, Yuanyuan Li, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Cancer Research|February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsAbdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.
Pageof 56